Advertisement MitoSciences introduces new tests for mitochondrial biogenesis - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

MitoSciences introduces new tests for mitochondrial biogenesis

MitoSciences has released two new products for measuring mitochondrial biogenesis, a crucial biological process that is receiving increased attention due to its link to increased life span and greater resistance to disease.

MitoSciences is offering two new solutions to researchers with the release of the MitoProfile Biogenesis kits. The MS631 MitoProfile Biogenesis Dipstick Kit is designed for point-of-care testing, and the MS641 MitoProfile Biogenesis Microplate Kit is designed for high-throughput analysis.

Both tests are said to be highly sensitive, while also being faster, easier and less expensive than existing methods for evaluating mitochondrial biogenesis. Both kits are for research use only, not for diagnostic testing, although the Biogenesis Dipstick Kit has been approved by the FDA for investigational use only, a designation for tests that are undergoing clinical validation.

Jean-Paul Audette, president of MitoSciences, said: “Our hope is that these new kits will provide useful tools to support some very promising areas of disease prevention research while also supporting ongoing research into the best and safest ways to administer antiviral and antibiotic drugs.”